Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Nakanishi Metal Works Co., Ltd., in connection with the acquisition of SKF’s cage manufacturing facility
Mandate

Vinge advises Nakanishi Metal Works Co., Ltd., in connection with the acquisition of SKF’s cage manufacturing facility

February 08, 2011

Vinge has advised the Japanese components manufacturer, Nakanishi Metal Works Co., Ltd., (NKC) in conjunction with the acquisition of a cage manufacturing facility in Gothenburg from SKF Sverige AB. SKF in Gothenburg produces spherical roller bearings and the cage constitutes the component within the bearing which keeps the rollers in place between the inner and outer rings. The facility is located at SKF’s production facility in Gothenburg and employs 130 people.

NKC was established in 1924 and is one of the world’s leading companies within cage manufacturing and pressed steel components including both as plastic and rubber processing.

Vinge advised NKC. Vinge’s team consisted of, among others, Fredrik Sonander, (responsible partner M&A), Daniel Ericson (real estate), Katja Cato (M&A), Anna Björk Larsson (M&A), Anna Engeström (employment), Anna Grandin (employment), and Maria Paijkull (environmental).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025